CN Stock MarketDetailed Quotes

Gan & Lee Pharmaceuticals. (603087)

Watchlist
  • 56.54
  • -0.16-0.28%
Market Closed May 15 15:00 CST
33.77BMarket Cap32.97P/E (TTM)

Gan & Lee Pharmaceuticals. (603087) Key Financial Indicators

603087 Earnings per Share (EPS)

According to the latest financial report of Gan & Lee Pharmaceuticals., the latest earnings per share (TTM) for the company is 0.33. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Gan & Lee Pharmaceuticals.'s latest financial report to see how much their book value per share (BVPS) is currently at 19.80.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Gan & Lee Pharmaceuticals. shows that the company's current ratio is 7.99, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Gan & Lee Pharmaceuticals., the quick ratio is 6.37, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Return on Equity (ROE)

Want to learn more about the financial health of Gan & Lee Pharmaceuticals.? The latest ROE figure is 1.64%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Gan & Lee Pharmaceuticals., the total asset return on investment (ROA) is 1.52%.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Gan & Lee Pharmaceuticals.'s latest financial report to see how their gross margin is doing - currently at 74.56%.

Currency: CNY

Cumulative Quarterly

Loading...

603087 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Gan & Lee Pharmaceuticals., the net profit margin is 21.92%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More